Human Genome Epidemiology Literature Finder
|
Records 1 - 18 (of 18 Records) |
| Query Trace: Liver Diseases and HSD17B13[original query] |
|---|
| 17-Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease. Hepatology (Baltimore, Md.) 2019 Apr 69 (4): 1504-1519. Ma Yanling, Belyaeva Olga V, Brown Philip M, Fujita Koji, Valles Katherine, Karki Suman, de Boer Ynto S, Koh Christopher, Chen Yanhua, Du Xiaomeng, Handelman Samuel K, Chen Vincent, Speliotes Elizabeth K, Nestlerode Cara, Thomas Emmanuel, Kleiner David E, Zmuda Joseph M, Sanyal Arun J, , Kedishvili Natalia Y, Liang T Jake, Rotman Yar |
| Splice variant rs72613567 prevents worst histologic outcomes in patients with nonalcoholic fatty liver disease. Journal of lipid research 2019 Jan 60 (1): 176-185. Pirola Carlos J, Garaycoechea Martin, Flichman Diego, Arrese Marco, San Martino Julio, Gazzi Carla, Castaño Gustavo O, Sookoian Silv |
| High Risk of Fatty Liver Disease Amplifies the Alanine Transaminase-Lowering Effect of a HSD17B13 Variant. Hepatology (Baltimore, Md.) 2019 Jun . Gellert-Kristensen Helene, Nordestgaard Børge Grønne, Tybjaerg-Hansen Anne, Stender Stef |
| A 17-Beta-Hydroxysteroid Dehydrogenase 13 Variant Protects From Hepatocellular Carcinoma Development in Alcoholic Liver Disease. Hepatology (Baltimore, Md.) 2019 Mar . Yang Jie, Trépo Eric, Nahon Pierre, Cao Qian, Moreno Christophe, Letouzé Eric, Imbeaud Sandrine, Bayard Quentin, Gustot Thierry, Deviere Jacques, Bioulac-Sage Paulette, Calderaro Julien, Ganne-Carrié Nathalie, Laurent Alexis, Blanc Jean Frédéric, Guyot Erwan, Sutton Angela, Ziol Marianne, Zucman-Rossi Jessica, Nault Jean-Charl |
| Genetic Variation in HSD17B13 Reduces the Risk of Developing Cirrhosis and Hepatocellular Carcinoma in Alcohol Misusers. Hepatology (Baltimore, Md.) 2019 Oct . Stickel Felix, Lutz Philipp, Buch Stephan, Nischalke Hans Dieter, Silva Ines, Rausch Vanessa, Fischer Janett, Weiss Karl Heinz, Gotthardt Daniel, Rosendahl Jonas, Marot Astrid, Elamly Mona, Krawczyk Marcin, Casper Markus, Lammert Frank, Buckley Thomas W M, McQuillin Andrew, Spengler Ulrich, Eyer Florian, Vogel Arndt, Marhenke Silke, von Felden Johann, Wege Henning, Sharma Rohini, Atkinson Stephen, Franke Andre, Nehring Sophie, Moser Vincent, Schafmayer Clemens, Spahr Laurent, Lackner Carolin, Stauber Rudolf E, Canbay Ali, Link Alexander, Valenti Luca, Grove Jane I, Aithal Guruprasad P, Marquardt Jens U, Fateen Waleed, Zopf Steffen, Dufour Jean-Francois, Trebicka Jonel, Datz Christian, Deltenre Pierre, Mueller Sebastian, Berg Thomas, Hampe Jochen, Morgan Marsha |
| HSD17B13 rs72613567 protects against liver diseases and histological progression of nonalcoholic fatty liver disease: a systematic review and meta-analysis. European review for medical and pharmacological sciences 2020 9 24 (17): 8997-9007. Wang P, Wu C-X, Li Y, Shen |
Genome-wide Association Study and Meta-analysis on Alcohol-Associated Liver Cirrhosis Identifies Genetic Risk Factors.
Hepatology (Baltimore, Md.) 2020 Aug . Schwantes-An Tae-Hwi, Darlay Rebecca, Mathurin Philippe, Masson Steven, Liangpunsakul Suthat, Mueller Sebastian, Aithal Guruprasad P, Eyer Florian, Gleeson Dermot, Thompson Andrew, Muellhaupt Beat, Stickel Felix, Soyka Michael, Goldman David, Liang Tiebing, Lumeng Lawrence, Pirmohamed Munir, Nalpas Bertrand, Jacquet Jean-Marc, Moirand Romain, Nahon Pierre, Naveau Sylvie, Perney Pascal, Botwin Greg, Haber Paul S, Seitz Helmut K, Day Christopher P, Foroud Tatiana M, Daly Ann K, Cordell Heather J, Whitfield John B, Morgan Timothy R, Seth Devanshi, |
| Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population. Hepatology (Baltimore, Md.) 2020 3 72 (3): 845-856. Gellert-Kristensen Helene, Richardson Tom G, Davey Smith George, Nordestgaard Børge G, Tybjaerg-Hansen Anne, Stender Stef |
| Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort. Hepatology communications 2021 Jun . Wang Jun, Conti David V, Bogumil David, Sheng Xin, Noureddin Mazen, Wilkens Lynne R, Le Marchand Loic, Rosen Hugo R, Haiman Christopher A, Setiawan Veronica Wen |
| Heterozygosity of the Alpha 1-Antitrypsin Pi*Z Allele and Risk of Liver Disease. Hepatology communications 2021 8 5 (8): 1348-1361. Hakim Aaron, Moll Matthew, Qiao Dandi, Liu Jiangyuan, Lasky-Su Jessica A, Silverman Edwin K, Vilarinho Silvia, Jiang Gordon Z, Hobbs Brian D, Cho Michael |
| Role of candidate gene variants in modulating the risk and severity of alcoholic hepatitis. Alcoholism, clinical and experimental research 2021 Feb . Beaudoin James J, Liang Tiebing, Tang Qing, Banini Bubu A, Shah Vijay H, Sanyal Arun J, Chalasani Naga P, Gawrieh Sam |
| The Health Impact of MAFLD, a Novel Disease Cluster of NAFLD, Is Amplified by the Integrated Effect of Fatty Liver Disease-Related Genetic Variants. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2021 1 20 (4): e855-e875. Liu Zhenqiu, Suo Chen, Shi Oumin, Lin Chunqing, Zhao Renjia, Yuan Huangbo, Jin Li, Zhang Tiejun, Chen Xingdo |
| Variants in mitochondrial amidoxime reducing component 1 and hydroxysteroid 17-beta dehydrogenase 13 reduce severity of nonalcoholic fatty liver disease in children and suppress fibrotic pathways through distinct mechanisms. Hepatology communications 2022 4 6 (8): 1934-1948. Hudert Christian A, Adams Leon A, Alisi Anna, Anstee Quentin M, Crudele Annalisa, Draijer Laura G, Furse Samuel, Hengstler Jan G, Jenkins Benjamin, Karnebeek Kylie, Kelly Deirdre A, Koot Bart G, Koulman Albert, Meierhofer David, Melton Phillip E, Mori Trevor A, Snowden Stuart G, van Mourik Indra, Vreugdenhil Anita, Wiegand Susanna, Mann Jake P, |
| MTARC1 and HSD17B13 Variants Have Protective Effects on Non-Alcoholic Fatty Liver Disease in Patients Undergoing Bariatric Surgery. International journal of molecular sciences 2022 12 23 (24): . Kalinowski Piotr, Smyk Wiktor, Nowosad Ma?gorzata, Paluszkiewicz Rafa?, Micha?owski ?ukasz, Ziarkiewicz-Wróblewska Bogna, Weber Susanne N, Milkiewicz Piotr, Lammert Frank, Zieniewicz Krzysztof, Krawczyk Marc |
| Does Genetic Variation in PNPLA3, TM6SF2 and HSD17B13 have a Role in the Development or Prognosis of Hepatocellular Carcinoma in Turkish Patients with Hepatitis B? Journal of gastrointestinal and liver diseases : JGLD 2024 6 33 (2): 203-211. Coskun Ozer Demirtas, Fatih Eren, Demet Yilmaz, Osman Cavit Ozdogan, Feyza Gund |
| The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes. Alimentary pharmacology & therapeutics 2024 6 . Lana Bridi, Saaket Agrawal, Kaleb Tesfai, Egbert Madamba, Ricki Bettencourt, Lisa M Richards, Amit V Khera, Rohit Loomba, Veeral Ajme |
| Use of PNPLA3, TM6SF2, and HSD17B13 for detection of fibrosis in MASLD in the general population. Clinics and research in hepatology and gastroenterology 2024 6 48 (7): 102389. Elias Badal Rashu, Mikkel Parsberg Werge, Liv Eline Hetland, Mira Thing, Puria Nabilou, Nina Kimer, Anders Ellekaer Junker, Anne-Sofie Houlberg Jensen, Børge Grønne Nordestgaard, Stefan Stender, Lise Lotte Glu |
| PNPLA3 risk allele is associated with risk of hepatocellular carcinoma but not decompensation in compensated cirrhosis. Hepatology communications 2024 5 8 (6): . Esteban Urias, Nicholas R Tedesco, Daniel A Burkholder, Isabel J Moran, Matthew J Miller, Venkata Sai J Jasty, Snehal Patil, Sebastian Zoellner, Karn Wijarnpreecha, Vincent L Ch |
- Page last reviewed:Feb 1, 2024
- Content source: